On (b)(6) 2019, abbott point of care was contacted by a customer regarding i-stat pt/inr cartridges that yielded a suspected discrepant pt/inr result of 47.3/4.2 on a (b)(6) year old male that arrived at the hospital intubated; non responsive and with an active gi bleed.There was no additional patient information available at the time of this report.Return product is available for investigation.(b)(6).At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The customer states that the patient is not on coumadin or warfarin.It was determined that the customer is not using i-stat pt/inr for its intended use.Per 715236-00s, the i-stat pt, a prothrombin time test, is useful for monitoring patients receiving oral anticoagulation therapy such as coumadin or warfarin.The customer also stated that the patient received fresh frozen plasma based on the i-stat result.Based on the information given that patient may have been unnecessarily transfused.This is an adverse event.The investigation is underway.
|